TG Therapeutics | TGTX - Capital Ordinário





Capital Ordinário Alterar Data
AbbVie USD 1.77B 1.75B 2025-06
Alaunos Therapeutics USD 2.38M 172K 2026-03
Amgen USD 541M 1000K 2026-06
Ardelyx USD 246.97M 2.62M 2026-03
Arrowhead Research USD 141.14M 564K 2026-06
Bayer EUR 982.42M 0 2026-06
Biogen USD 146.7M 200K 2025-09
Corcept Therapeutics USD 107.33M 1.36M 2026-03
Curis USD 2M 10.93M 2026-03
Gilead Sciences USD 1.24B 1000K 2026-06
J&J USD 2.41B 1.64M 2026-06
Karyopharm Therapeutics USD 22.54M 4.23M 2026-03
Novartis USD 1.9B 7.38M 2026-06
Novavax USD 162.58M 106K 2025-12
PTC Therapeutics USD 82.88M 1.41M 2026-03
Puma Biotechnology USD 5K 0 2024-06
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Roche Holding CHF 796.77M 1.15M 2026-06
TG Therapeutics USD 153.08M 2.23M 2026-06
Verastem USD 87.84M 10.1M 2026-03
Vertex Pharmaceuticals USD 253.3M 900K 2026-06